Premium
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease—Authors’ reply
Author(s) -
Christensen B.,
Gibson P. R.,
Rubin D. T.
Publication year - 2018
Publication title -
alimentary pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14638
Subject(s) - vedolizumab , medicine , inflammatory bowel disease , disease , gastroenterology , autoimmune disease , immunology